The Chart of the Day belongs to Marinus Pharmaceuticals (MRNS). Since the Trend Spotter signaled a buy on 6/21 the stock gained 319.15%.

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.

(Click on image to enlarge)

Barchart technical indicators:

• 100% technical buy signals
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 9 new highs and up 103.45% in the last month
• Relative Strength Index 82.96%
• Technical support level at 5.00
• Recently traded at 5.81 with a 50 day moving average of 3.00

Fundamental factors:

• Market Cap $168 million
• Earnings estimated to increase 49.70% this year and an additional 24.30% next year
• The only analyst following the stock rated it a buy
•  to The individual investors following the stock on Motley Fool voted that the stock will beat the market